CURRENT
ISSUE1557
October 8, 2018
Intrauterine devices (IUDs) and the etonogestrel
implant are the most effective reversible contraceptive
methods available. Hormonal oral contraceptives,
patches, rings, and injectables are also highly effective
in preventing pregnancy. When used alone, barrier and
fertility-based methods generally have higher failure
rates than other... read more...
More from issue 1557
Featured Article
Coming Soon
Tezacaftor/Ivacaftor (Symdeko) for Cystic Fibrosis
Influenza Vaccine for 2018-2019
Plazomicin (Zemdri) for Complicated Urinary Tract Infection
Drugs for Cough
Recommend to Your Library
We're Essential. Begin your free trial
Previous Issues
September 24, 2018 (1556)
- Antiviral Drugs for Varicella-Zoster Virus and Herpes Simplex Virus Infections
- Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratoses
- Elagolix (Orilissa) - An Oral GnRH Antagonist for Endometriosis Pain
- Table: Mechanisms of Drug Interactions (online only)
September 10, 2018 (1555)
- Roxybond - An Abuse-Deterrent Formulation of Short-Acting Oxycodone
- Imvexxy - Another Estradiol Vaginal Insert for Dyspareunia
- Osmolex ER - Another Extended-Release Amantadine for Parkinson's Disease
- Obiltoxaximab (Anthim) for Inhalational Anthrax
- A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
- Lutetium Lu 177 Dotatate (Lutathera) for Gastroenteropancreatic Neuroendocrine Tumors (online only)
August 27, 2018 (1554)
- Management of Opioid Withdrawal Symptoms
- Two New Intra-Articular Injections for Knee Osteoarthritis
- Expanded Table: Some Drugs for Management of Opioid Withdrawal Symptoms (online only)
August 13, 2018 (1553)
- Sunscreens
- Biktarvy - Another INSTI-Based Combination for HIV
- Ciprofloxacin Otic Suspension (Otiprio) for Acute Otitis Externa
- In Brief: More Fluoroquinolone Warnings
July 30, 2018 (1552)
